These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 932428)

  • 41. Nonspecific inhibition of tumor growth in vivo by admixed allogeneic tumor-sensitized lymphoid cells and identical inactivated allogeneic tumor cells.
    Sendo F; Nakayama M; Gotohda E; Kobayashi
    J Immunol; 1976 Oct; 117(4):1340-5. PubMed ID: 61998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Reduced malignancy of hybrids of tumor cells fused with lymph node lymphocytes of syngeneic rats].
    Zalmanzon ES; Grigor'eva LV; Pogrebniak NIa; Kushch AA; Turetskaia RL
    Vopr Onkol; 1987; 33(5):62-9. PubMed ID: 3590669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effects of adult thymectomy on the growth of 203-glioma in mice--analysis of T cell subpopulation in tumor immunology].
    Yamasaki T; Yamashita J; Handa H; Namba Y; Hanaoka M
    No To Shinkei; 1982 Nov; 34(11):1067-75. PubMed ID: 6984337
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro.
    Cheever MA; Greenberg PD; Fefer A
    Cancer Res; 1981 Jul; 41(7):2658-63. PubMed ID: 7018668
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of exogenous RNA preparations on the antitumor activity of the splenocytes in C3HA mice].
    Aksenova NN; Golosova IuV; Fel' VIa
    Tsitologiia; 1984 Jun; 26(6):729-34. PubMed ID: 6084886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of autosensibilization of lymphoid cells in genesis of antitumor resistance.
    Malygin AM; Fel VJ
    Neoplasma; 1979; 26(4):429-37. PubMed ID: 522915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of syngeneic sensitized lymphoid cells on incidence and growth of methyl cholanthrene-induced and spontaneous tumors in mice.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):494-503. PubMed ID: 965050
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of normal syngeneic lymphoid cells on growth of methyl cholanthrene induced fibrosarcomas in mice.
    Gautam S; Aikat BK
    Indian J Med Res; 1976 Mar; 64(3):482-93. PubMed ID: 965049
    [No Abstract]   [Full Text] [Related]  

  • 52. Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.
    Eberlein TJ; Rosenstein M; Rosenberg SA
    J Exp Med; 1982 Aug; 156(2):385-97. PubMed ID: 6980254
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of the enzyme neuraminidase for immunotherapeutic treatment of chemically induced carcinogenesis].
    Maĭskiĭ IN; Aĭrapet'ian GP; Kobrinskiĭ GD; Troitskaia NA; Gudkova GB
    Biull Eksp Biol Med; 1977 Dec; 84(12):714-7. PubMed ID: 413595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors.
    Johnson RJ; Siliciano RF; Shin HS
    J Immunol; 1979 Feb; 122(2):379-82. PubMed ID: 581674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of "eclipsed" lymphoid cells from advanced tumor-bearing mice through adoptive transfer to sublethally irradiated syngeneic hosts.
    Youn JK; Le Francois D; Hue G; Santillana M; Barski G
    Int J Cancer; 1975 Oct; 16(4):629-38. PubMed ID: 1176209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing lymphocytes in spleens of tumor-bearing mice: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    Int J Cancer; 1977 Aug; 20(2):239-46. PubMed ID: 892934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Separation of lymphoid cells with a suppressor effect on the activity of cytotoxic cells in vitro during the growth of a syngeneic mouse tumour.
    Schaaf-Lafontaine N
    Int J Cancer; 1978 Mar; 21(3):329-33. PubMed ID: 631933
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.
    Bowlin TL; Proffitt MR
    Cancer Immunol Immunother; 1982; 13(1):30-7. PubMed ID: 6984353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transfer of a primary immune response by homologous sensitized cells.
    Milas L; Suit HD
    Transplantation; 1969 Sep; 8(3):215-9. PubMed ID: 4908382
    [No Abstract]   [Full Text] [Related]  

  • 60. Cellular immunoabsorbents in transplantation immunity. Specific in vitro deletion and recovery of mouse lymphoid cells sensitized against allogeneic tumors.
    Berke G; Levey RH
    J Exp Med; 1972 Apr; 135(4):972-84. PubMed ID: 4622914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.